Guardant Health
GH
#3559
Rank
S$4.02 B
Marketcap
$32.68
Share price
-1.18%
Change (1 day)
-12.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -S$0.66 B

According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -S$0.64 B. In 2023 the company made an earning of -S$0.63 B an increase over its 2022 earnings that were of -S$0.86 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.66 B5.56%
2023 -S$0.63 B-26.73%
2022 -S$0.86 B69.96%
2021 -S$0.51 B56.35%
2020 -S$0.33 B252.69%
2019 -S$90.82 M-17.22%
2018 -S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.38 B-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$18.64 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA